Kossan Rubber Industries has received the Global Medical Gloves Technology Innovation Company of the Year at the 2017 Frost & Sullivan Asia-Pacific Best Practices Awards banquet, held at the Shangri-La Singapore on 4 October 2017, for their novel glove technology, LOW DERMA™.

The global medical gloves market is increasingly becoming more competitive, and accurately gauging customer needs and leveraging on technological innovation is a necessity in the current landscape. Based on this, Kossan Rubber Industries developed the LOW DERMA™ Technology, which core value offers ‘Clean and Safe’ protection for its users by focusing on two key fundamental rights: 1) The right to be protected and 2) The right to protect. As a result, this technology embarks on a journey to create the best and safest glove choice for users and the people under their care.

"Kossan has leveraged its expertise and depth of market understanding to identify specific customer needs, resulting in the development of the ground-breaking, patented LOW DERMA™ Technology in 2016 and making it the first glove manufacturer in the world to be granted the ‘low dermatitis potential’ claim in gloves by the U.S. FDA," said Ms. Geeta Dhanoa, associate director, Transformational Health, Frost & Sullivan Asia-Pacific.

She continued, "Kossan has successfully differentiated itself with this new technology, enabling the development of new generation of products that will further strengthen its position in the global market."

"We are proud to receive the 2017 Global Medical Gloves Technology Innovation Company of the Year award from Frost & Sullivan. This recognition will further motivate us to develop new and innovative products that will benefit the market," said Tan Sri Dato’ KS Lim, group managing director/CEO of Kossan Rubber Industries.

The recipients of the annual Frost & Sullivan Asia-Pacific Best Practices Awards are identified based on an in-depth research conducted by Frost & Sullivan’s analysts. The award categories offered each year are carefully reviewed and evaluated to reflect the current market landscape and include new emerging trends. The short-listed companies were evaluated on a variety of actual market performance indicators which include revenue growth; market share and growth in market share; leadership in product innovation; marketing strategy and business development strategy.